SCHEMBL17295528

SCHEMBL17295528

O=C1C(=Cc2ccc3[nH]cnc3c2)SC(=NCc2ccccc2)N1Cc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.62
▸ MAPT P10636 3/20 0.62
▸ HPGD P15428 1/20 0.62
▸ NPSR1 Q6W5P4 2/20 0.60
▸ LMNA P02545 1/20 0.60
▸ HTT P42858 1/20 0.60
▸ MEN1 O00255 2/20 0.59
▸ GAA P10253 2/20 0.59
▸ KMT2A Q03164 2/20 0.59
▸ ATM Q13315 1/20 0.59
▸ S1PR1 P21453 1/20 0.47
▸ S1PR3 Q99500 1/20 0.47
▸ CA9 Q16790 11/20 0.47
▸ CA2 P00918 1/20 0.47
▸ PTPN1 P18031 2/20 0.45
▸ ACP1 P24666 2/20 0.45
▸ POLB P06746 1/20 0.44
▸ HSP90AA1 P07900 1/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17295526 1.00 ALDH1A1 (0.62) ALDH1A1MAPTHPGDNPSR1LMNA
SCHEMBL17295379 0.91 MAPT (0.51) ALDH1A1MAPTHPGDNPSR1LMNA
SCHEMBL17295378 0.91 MAPT (0.51) ALDH1A1MAPTHPGDNPSR1LMNA
SCHEMBL17295287 0.89 ALDH1A1 (0.49) ALDH1A1MAPTHPGDNPSR1LMNA
SCHEMBL17295285 0.89 ALDH1A1 (0.49) ALDH1A1MAPTHPGDNPSR1LMNA
SCHEMBL17295405 0.89 CA9 (0.60) CA9CA2PTPN1ACP1
SCHEMBL17295403 0.89 CA9 (0.60) CA9CA2PTPN1ACP1
SCHEMBL17295448 0.88 ALDH1A1 (0.51) ALDH1A1MAPTHPGDNPSR1LMNA
SCHEMBL17295444 0.88 ALDH1A1 (0.51) ALDH1A1MAPTHPGDNPSR1LMNA
SCHEMBL17295639 0.87 S1PR1 (0.48) ALDH1A1MAPTHPGDNPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148990-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2017-04-05 — — EP disclosed
WO-2015181337-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback